Medplus Health Services Limited IPO Message Board (Page 23)

Gmp 210

some items are having grave concerns i.e. price / cost of share to promoters or other investors. it is less than 200 per piece and also allotted in nov 2021.
another is PE ratio i.e. 160, company only giving profit to promoters/investors not to the investors entering now. there may be no profit or less profit in coming 2-3 years on invested money. better to avoid and buy after lock in period of anchor investors. It is not much different than Star. Metro or paytm.

Latest GMP 200-210

GMP 270 rajkot

GMP 220--225

Employee quota over subscribed in two days. Good sign

Why is QIB subscription so low? Why are institutional bidders staying away from this ipo.. I thought it was very good? Experts what is your opinion?

Always come last day qib and hni

Isn''t this a highly competitive business ? Experts could you please guide.. Thanks

Experts kindly suggest listings gain possible or not in medplus???

200+ if market remains dull. Bumper listing if market turns around from here. (not an expert)

What is current GMP of this counter ?

260

What is current GMP of this counter ?

Medplus Health being Second Largest pharmacy retailer .... valued at around $1.2-1.3B
can we compare this with Pharmeasy from unlisted stock (at 110-120/- per share) is valued at $9-10B
?
I have heard good review about Medplus compared to other options...

Requesting Experts to give your view on it .
Thank you

Also please clarify pharmeasy parent API holding filed for drhp but pharmeasy shares is trading in unlisted what is difference between them and is it good to buy pharmeasy in unlisted

the stock that are trading in unlisted is API HOLDING only... which is Pharmeasy...
and yes they have filed DRHP....

Well i will not buy Pharmeasy at $9-10B....

my point is now if Medplus market would be 9300 cr whereas Pharmeasy is valued at 70000cr.
and Medplus has better revenue then Pharmeasy...
so now the point will be at what valuation Pharmeasy will come for IPO... when compared to it Medplus will be already listed at much lower valuation with better revenue.

GMP UPDATES.

RateGain Rs 30/- {+/- Rs 5/-}
S.RAM PR. Rs 17/- {+/- Rs 1/-}
METRO Rs 15/- {+/- Rs 2/-}

C.E. INFO S Rs 1,050/- {+/- Rs 10/-}
DATA PAT Rs 550/- {+/- Rs 5/-}
MEDPLUS Rs 200/- {+/- Rs 5/-}
SUPRIYA Rs 275/- {+/- Rs 10/-}

Apply at your own discretion.

Thanks

Applied 5 retail applications..☑️
Hope for 2

Funds aren''t enough for data patterns, SME nupur recyclers, and money blocked is mapmyindia......
So only 5

Update....
Cancelled all 5 applications in this....
Diverted that money in data pattern....(total 21 applications done in data pattern)☑️

*ANAND RATHI IPO PRICE SETTLED IN PRE MATCHING*

ISSUE PRICE: Rs 550.00

LISTING PRICE
BSE: Rs 602.05
NSE: Rs 600.00

Third party UPI aacepted or not?

I used to apply third-party UPI. Never allotted any!

Better to avoid third-party UPI.

Gmp please

240 seller

Jo haal krsnaa ka hua wahi iska bhi hoga .
High valuation par yeh tikega nhi .
Not much listing gain .

Valuations are very very expensive as per current EPS, don''t know where it lands but i am expecting some correction in valuations after listing.

Management trying to double the number of store in upcoming 2-3 years, which may make this counter attractive after some correction.

Retail funds may flow to Data pattern, i am expecting less than 10x subscription

I think It is another tarson type listing

Krupa Everyday is not sunday.

This will give Decent Profits. Apply with Full Force. Chance of Getting in Data Pattern is minimal, so its time to concentrate here.

Though Expensive, but good growth shown in last couple of Quarter. No Listed Peers, so something to play for.

@krupa sir gmp dekho zara.